TipRanks on MSN

Q-linea Submits FDA Application for Expanded ASTar BC G- Panel Claims

Q-linea AB ( ($SE:QLINEA) ) has shared an update. Q-linea AB has submitted a 510(k) application to the FDA for expanded organism and antimicrobial ...
TipRanks on MSN

Celcuity submits gedatolisib new drug application to the FDA

Celcuity (CELC) announced the completion of the submission of its new drug application to the FDA for gedatolisib in hormone receptor positive, ...

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...
The Caledonian-Record

Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of ...
MedTech Dive

Zimmer wins FDA clearance for updated knee robot

Competing with companies including Stryker and J&J, Zimmer has moved to strengthen its position by developing an updated ...

Veri Medtech (VRHI) Files Registration Statement for Proposed Initial Public Offering

About Veriheal: Veriheal, a wholly-owned subsidiary of publicly-traded Veri Medtech Holdings - OTC Markets (“VRHI”), is a healthcare technology company on a mission to help people gain access to ...